Evidence map›Paper›PMID 32370925›Full record

Observational studyJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2020

Association of Blood Pressure and Cognition after Stroke.

Deborah A Levine, Andrzej T Galecki, Dolorence Okullo, Emily M Briceño, Mohammed U Kabeto, Lewis B Morgenstern, Kenneth M Langa, Bruno Giordani, Robert Brook, Brisa N Sanchez and 1 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Deborah A LevineDepartments of Internal Medicine and Neurology, and University of Michigan Cognitive Health Services Research Program, University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: deblevin@umich.edu.
Andrzej T GaleckiDepartment of Internal Medicine, University of Michigan Medical School, and Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan.
Dolorence OkulloDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Emily M BriceñoDepartment of Physical Medicine and Rehabilitation, University of Michigan Medical School, Ann Arbor, Michigan.
Mohammed U KabetoDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Lewis B MorgensternDepartment of Neurology, University of Michigan, Ann Arbor, Michigan.
Kenneth M LangaDepartment of Internal Medicine, University of Michigan Medical School and VA Ann Arbor Healthcare System, Ann Arbor, Michigan.
Bruno GiordaniDepartments of Psychiatry and Neurology, University of Michigan Medical School, Professor of Psychology, University of Michigan College of Literature, Science, and the Arts, Ann Arbor, Michigan.
Robert BrookDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Brisa N SanchezDepartment of Epidemiology and Biostatistics, Drexel University, Dornsife School of Public Health, Philadelphia, Pennsylvania.
Lynda D LisabethDepartment of Neurology, University of Michigan Medical School, and Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.
University of Michigan · USDrexel University · US

Funding

Research Education CoreP30AG024824 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Neil Alexander · 2004 to 2026
$29.2M
Michigan Alzheimer's Disease Core CenterP30AG053760 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALBIN, ROGER L · 2016 to 2020
$10.1M
Dementia Prevalence over Time: Proximate Causes and ConsequencesR01AG053972 · NIA · RAND CORPORATION · PI HURD, MICHAEL D · 2016 to 2021
$4.9M
The Effect of Lower Blood Pressure over the Life Course on Late-life Cognition in Blacks, Hispanics, and Whites (BP-COG)R01NS102715 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEVINE, DEBORAH ALLISON · 2017 to 2021
$3.8M
The Predictors and Long-Term Trajectory of Poststroke Cognitive DeclineK23AG040278 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEVINE, DEBORAH ALLISON · 2012 to 2015
$637k
NIA NIH HHS K23 AG040278NIA NIH HHS P30 AG024824NIA NIH HHS P30 AG053760NIA NIH HHS R01 AG053972NINDS NIH HHS R01 NS102715
6 · The paper itself

Abstract

BACKGROUND AND

aimIt is unclear whether blood pressure (BP) is associated with cognition after stroke. We examined associations between systolic and diastolic BP (SBP, DBP), pulse pressure (PP), mean arterial pressure (MAP), and cognition, each measured 90 days after stroke.

methodsCross-sectional analysis of prospectively obtained data of 432 dementia-free subjects greater than or equal to 45 (median age, 66; 45% female) with stroke (92% ischemic; median NIH stroke score, 3 [IQR, 2-6]) from the population-based Brain Attack Surveillance in Corpus Christi (BASIC) project in 2011-2013. PRIMARY OUTCOME: Modified Mini-Mental Status Examination (3MSE; range, 0-100). SECONDARY OUTCOMES: Animal Fluency Test (AFT; range, 0-10) and Trail Making Tests A and B (number of correct items [range, 0-25]/completion time [Trails A: 0-180 seconds; Trails B: 0-300 second]). Linear or tobit regression adjusted associations for age, education, and race/ethnicity as well as variables significantly associated with BP and cognition.

resultsHigher SBP, lower DBP, higher PP, and lower MAP each were associated with worse cognitive performance for all 4 tests (all P < .001). After adjusting for patient factors, no BP measures were associated with any of the 4 tests (all P > .05). Lower cognitive performance was associated with older age, less education, Mexican American ethnicity, diabetes, higher stroke severity, more depressive symptoms, and lower BMI. Among survivors with hypertension, anti-hypertensive medication use 90 days after stroke was significantly associated with higher AFT scores (P = .02) but not other tests (P > .15).

conclusionsStroke survivors' BP levels were not associated with cognitive performance at 90 days independent of sociodemographic and clinical factors.

Indexed as

Blood PressureCognitionAgedAntihypertensive AgentsCognition DisordersCross-Sectional StudiesDisability EvaluationExecutive FunctionFemaleHumansHypertensionMaleMental Status and Dementia TestsMexican AmericansMiddle AgedNeuropsychological TestsAntihypertensive Agentsblood pressurecognitionethnic groupsStroketreatment

Identifiers

PMID32370925
PMCPMC7934908
OpenAlexW3023705269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.